Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. (window အသစ် ဖွင့်နေပါတယ်)

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

ရင်းမြစ်‎: Hemoglobin 2014;38(1):44-8.

Index လုပ်ထား‎: PubMed 24144212

DOI‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 (window အသစ် ဖွင့်နေပါတယ်)

Hydroxyurea in thalassemia intermedia--a promising therapy. (window အသစ် ဖွင့်နေပါတယ်)

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

ရင်းမြစ်‎: Ann Hematol 2005;84(7):441-6.

Index လုပ်ထား‎: PubMed 15838670

DOI‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 (window အသစ် ဖွင့်နေပါတယ်)

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. (window အသစ် ဖွင့်နေပါတယ်)

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

ရင်းမြစ်‎: J Clin Pathol 2010;63(2):147-50.

Index လုပ်ထား‎: PubMed 20154037

DOI‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 (window အသစ် ဖွင့်နေပါတယ်)

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. (window အသစ် ဖွင့်နေပါတယ်)

Karimi M, Borzouee M, Mehrabani A, Cohan N.

ရင်းမြစ်‎: Eur J Haematol 2009;82(3):213-8.

Index လုပ်ထား‎: PubMed 19077048

DOI‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 (window အသစ် ဖွင့်နေပါတယ်)

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. (window အသစ် ဖွင့်နေပါတယ်)

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

ရင်းမြစ်‎: Eur J Haematol 2010;84(1):52-8.

Index လုပ်ထား‎: PubMed 19799627

DOI‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 (window အသစ် ဖွင့်နေပါတယ်)

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. (window အသစ် ဖွင့်နေပါတယ်)

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

ရင်းမြစ်‎: Blood Cells Mol Dis 2000;26(5):453-66.

Index လုပ်ထား‎: PubMed 11112383

DOI‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 (window အသစ် ဖွင့်နေပါတယ်)

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (window အသစ် ဖွင့်နေပါတယ်)

Perrine SP.

ရင်းမြစ်‎: Pediatr Ann 2008;37(5):339-46.

Index လုပ်ထား‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 (window အသစ် ဖွင့်နေပါတယ်)

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. (window အသစ် ဖွင့်နေပါတယ်)

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

ရင်းမြစ်‎: Ann N Y Acad Sci 2005;1054:250-6.

Index လုပ်ထား‎: PubMed 16339672

DOI‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 (window အသစ် ဖွင့်နေပါတယ်)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (window အသစ် ဖွင့်နေပါတယ်)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

ရင်းမြစ်‎: Acta Haematol 2004;111(4):189-95.

Index လုပ်ထား‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (window အသစ် ဖွင့်နေပါတယ်)

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. (window အသစ် ဖွင့်နေပါတယ်)

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

ရင်းမြစ်‎: Blood Purif 2004;22(5):453-60.

Index လုပ်ထား‎: PubMed 15359104

DOI‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 (window အသစ် ဖွင့်နေပါတယ်)

The role of recombinant human erythropoietin in the treatment of thalassemia. (window အသစ် ဖွင့်နေပါတယ်)

Rachmilewitz EA, Aker M.

ရင်းမြစ်‎: Ann N Y Acad Sci 1998;850:129-38.

Index လုပ်ထား‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 (window အသစ် ဖွင့်နေပါတယ်)

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. (window အသစ် ဖွင့်နေပါတယ်)

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

ရင်းမြစ်‎: Br J Haematol 2011;154(2):281-4.

Index လုပ်ထား‎: PubMed 21496003

DOI‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 (window အသစ် ဖွင့်နေပါတယ်)

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. (window အသစ် ဖွင့်နေပါတယ်)

Thein SL.

ရင်းမြစ်‎: Blood Rev 2012;26 Suppl 1:S35-9.

Index လုပ်ထား‎: PubMed 22631042

DOI‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 (window အသစ် ဖွင့်နေပါတယ်)